These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34854066)

  • 1. Nonalcoholic fatty liver disease: lifestyle and quality of life.
    Vachliotis I; Goulas A; Papaioannidou P; Polyzos SA
    Hormones (Athens); 2022 Mar; 21(1):41-49. PubMed ID: 34854066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
    Kim SK; Kim KI; Kim SR
    Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.
    Ezzat WM
    World J Gastroenterol; 2024 May; 30(20):2633-2637. PubMed ID: 38855152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Roeb E; Geier A
    Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis.
    Pydyn N; Miękus K; Jura J; Kotlinowski J
    Pharmacol Rep; 2020 Feb; 72(1):1-12. PubMed ID: 32016853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.
    Zelber-Sagi S; Ratziu V; Oren R
    World J Gastroenterol; 2011 Aug; 17(29):3377-89. PubMed ID: 21876630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diet and lifestyle changes in nonalcoholic fatty liver disease.
    Nseir W; Hellou E; Assy N
    World J Gastroenterol; 2014 Jul; 20(28):9338-44. PubMed ID: 25071328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.
    Makri E; Goulas A; Polyzos SA
    Arch Med Res; 2021 Jan; 52(1):25-37. PubMed ID: 33334622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered.
    Plaz Torres MC; Aghemo A; Lleo A; Bodini G; Furnari M; Marabotto E; Miele L; Giannini EG
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Glass L; Asefa H; Volk M; Lok AS; Tincopa MA
    Dig Dis Sci; 2022 Jun; 67(6):2123-2133. PubMed ID: 34043121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance.
    Zelber-Sagi S; Ivancovsky-Wajcman D; Fliss Isakov N; Webb M; Orenstein D; Shibolet O; Kariv R
    J Hepatol; 2018 Jun; 68(6):1239-1246. PubMed ID: 29571924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.